Filing Details
- Accession Number:
- 0001193805-25-000923
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2025-06-20 17:15:45
- Reporting Period:
- 2025-06-04
- Filing Date:
- 2025-06-20
- Accepted Time:
- 2025-06-20 17:15:45
- Original Submission Date:
- 2025-06-06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1773673 | Daniel Vitt | 1200 Avenue Of The Americas, Suite 200 New York NY 10036 | Ceo And Director | Yes | Yes | No | No |
Transaction Summary
Purchased: | 15,000 shares | Avg. Price: $0.77 | Total Value: $11,550.00 |
Number of Shares After Transactions: | 29,000 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-06-04 | 15,000 | $0.77 | 29,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2025-06-05 | 1,558,000 | $0.00 | 1,558,000 | $0.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,558,000 | 2035-06-05 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 362,877 | Indirect | See footnote |
Footnotes
- The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).
- 362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.
- 25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.